• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

DACS SC (Buoyant Density Solution 60)

Product: DACS SC (Buoyant Density Solution 60)
Dendreon Corp., Seattle, WA
PMA number:
Indication for Use:
Processing autologous mobilized peripheral blood progenitor cells (PBPC) collected by leukapheresis to reduce RBC, platelets and granulocytes in the final PBPC product.
Approval Date:


Label (PDF - 761 KB)

Summary (PDF - 1.02 MB)


Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002